Stay updated on JAK1 Inhibitor With Topical Therapy Clinical Trial
Sign up to get notified when there's something new on the JAK1 Inhibitor With Topical Therapy Clinical Trial page.

Latest updates to the JAK1 Inhibitor With Topical Therapy Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe web page has been updated from version v2.15.0 to v2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check20 days agoChange DetectedThe page has been updated to include new information about the study on Atopic Dermatitis, specifically the addition of the study identifier B7451036 JADE TEEN and a link for obtaining contact information for study centers. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference9%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check42 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check71 days agoChange DetectedThe webpage has removed a notice regarding heavy traffic affecting NLM-NCBI services and a link to obtain contact information for a study center provided by Pfizer.SummaryDifference0.7%
- Check87 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.5%
Stay in the know with updates to JAK1 Inhibitor With Topical Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JAK1 Inhibitor With Topical Therapy Clinical Trial page.